Flu variants lose virulence with new drug, study finds.
Flu strains resistant to new drug; lab and animal studies show weakened effects - Georgia State Univ. researchers.
Stay updated with breaking news from Michaelg Natchus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Flu strains resistant to new drug; lab and animal studies show weakened effects - Georgia State Univ. researchers.
Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral Research at Georgia State University.
These results lay a foundation and establish the clinical potential of the AVG inhibitor class
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.